MUPIROCIN OINTMENT

TEVA

Revision date : 2014-03-04

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

500-038-2/25322-68-3

Name of the chemical

polyethyleneglycol

Concentration

N/A

General Information

Revision date

2014-03-04

Product name

MUPIROCIN OINTMENT

Chemical name

(E)-(2S 3R 4R 5S)-5-[(2S 3S 4S 5S)-2 3-Epoxy-5-hydroxy-4- methylhexyl]tetrahydro-3 4-dihydroxy-β- methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid

1.2.1 Relevant identified uses

of the PRODUCT

1.2.2. Uses advised against

Other than Relevant Use HOW SUPPLIED 20 mg in 1 g Clear Ointment NDC 0093-1010-42 22 g in 1 tube

Manufacturer Name

TEVA

Emergency telephone

1-800/424-9300, 01-703-527-3887

Icons in SDS

M004 M009 M010 M011 M017 M059

Company Information

company name

TEVA

e-mail address of the competent person responsible for the Safety Data Sheet

TevaSDSRequest@tevapharm.com

Section 2

SECTION 2: Hazards identification

Product definition

This product is a colorless to pale yellow ointment with a mild odor

Health hazards

In the workplace, exposure via inhalation or eye contact may cause irritation. Prolonged skin contact may cause redness or skin discomfort. Ingestion may be harmful. In therapeutic use, the most common adverse effects reported included rash, nausea, reddening of skin, dry skin, tenderness, swelling, contact dermatitis, and increased pus (when present). Prolonged therapeutic use may cause an overgrowth of non-susceptible organisms, including fungi. These effects may be possible as a result of workplace exposure. See Section 11 (Toxicological Information) for information on other potential health hazards known from therapeutic use. Flammability Hazards: This product is combustible and may ignite if exposed to direct flame or if highly heated for a prolonged period. When involved in a fire, this product may decompose and produce irritating vapors and toxic compounds, including carbon and nitrogen oxides, ethylene glycol, formaldehyde, formic acid, glyoxal, and dioxalane. Reactivity Hazards: This product is not reactive.

Environmental hazards

Large quantities released to the aquatic and terrestrial environment may have an adverse effect Emergency Considerations: Emergency responders should wear appropriate protection for the situation to which they respond.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.